As RPS6KA1 has been reported to mediate cell survival by phosphorylating and thus inhibiting the pro-apoptotic proteins BAD and DAPK1 [28, 29], we questioned whether BI-D1870 treatment might induce apoptotic cell death of AML cells. The gene discussed is RPS6KA1; the disease is acute myeloid leukemia.